| 摘要 |
The invention pertains to methods and compositions for treating medical disorders characterized by elevated levels or abnormal expression of TNFalpha by administering a TNFalpha inhibitor, such as recombinant TNFR:Fc, and to combination treatments involving the administration of a TNFalpha inhibitor.
|
